The skin is highly sensitive to the
chemical warfare agent in
mustard gas,
sulfur mustard (SM) that initiates a delayed injury response characterized by
erythema,
inflammation and severe
vesication (blistering). Although SM poses a continuing threat, used as recently as in the Syrian conflict, no mechanism-based antidotes against SM are available. Recent studies demonstrated that Transient Receptor Potential
Ankyrin 1 (TRPA1), a chemosensory
cation channel in sensory nerves innervating the skin, is activated by SM and
2-chloroethyl ethyl sulfide (
CEES), an SM analog, in vitro, suggesting it may promote
vesicant injury. Here, we investigated the effects of TRPA1 inhibitors, and an inhibitor of
Calcitonin Gene Related Peptide (CGRP), a neurogenic inflammatory
peptide released upon TRPA1 activation, in a
CEES-induced mouse ear
vesicant model (
CEES-MEVM). TRPA1 inhibitors (HC-030031 and A-967079) and a CGRP inhibitor (MK-8825) reduced skin
edema, pro-inflammatory
cytokines (IL-1β, CXCL1/KC), MMP-9, a
protease implicated in skin damage, and improved histopathological outcomes. These findings suggest that TRPA1 and
neurogenic inflammation contribute to the deleterious effects of
vesicants in vivo, activated either directly by alkylation, or indirectly, by reactive intermediates or pro-inflammatory mediators. TRPA1 and CGRP inhibitors represent new leads that could be considered for validation and further development in other
vesicant injury models.